Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SimpliciT1: TTP399 in Type 1 Diabetes
NCT03335371Phase 2Completed
- Sponsor
- vTv Therapeutics
- Start
- Oct 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cadisegliatin in type 1 diabetes mellitus (T1D), sponsored by vTv Therapeutics. Started Oct 2017; status: completed.
02
Drugs
cadisegliatin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03335371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03335371.